Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
September 20, 2005
Volume VI, Issue 80
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

Comments in the BLOG

Not surprisingly, the FED raised interest rates another 1/4 point today. Despite the rhetoric suggesting a "Katrina Pause" was appropriate, the FED continues on it's relentless march to keep inflation under control. Fueling perceptions of future inflation are energy prices (how can the price of gas not be inflationary?) and the soaring prices of other commodities. Gold hit a 17 year high this week.

A greater cause for future inflation pressure is the Bush's administration's policies on taxes and spending. This past week, the Bush administration re-asserted it's game plan to continue cutting taxes. This - in the face of paying for the War in Iraq and the Katrina Disaster.

This policy will result in major fiscal stimulus- after all, the US Government is literally printing money to finance it's cash short fall. It's as if someone gave you a handful of money you didn't earn and told you to spend it. According to the theory of Multiplier Effect, any money spent equates to more in GDP than the amount of money you spent. If you buy a home, the builder has more money to spend. The real estate agent makes a commission and buys a new car. The new car salesman buys a new home, and on and on. It is money in motion.

All this is still setting us up for the standard 4th quarter rally, and I am like a kid in a candy shop when I look at some of the current prices of stocks. If it's not energy, it's not trading very well. Just like the quick 33% rally we got in DSEN, several others are poised to rebound off oversold levels. HESG should follow suit tomorrow. Jump in early if you want to get on board. I'll post a BLOG on the trading activity in the morning.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG will scroll down automatically on the right side of your screen. The most current journal entries appear in the middle of your screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels or in volatile markets. Your questions and postings do not automatically appear, so don't bother posting the same question multiple times. I personally go through to moderate and respond to every question.

If you've been waiting for my previously announced new idea in the biotech arena, there has been a temporary delay, but it's coming. 
 

Health Sciences Group (OTC BB: HESG): Order Flow For SHUGR™ Picking Up

I haven't written any follow up on Health Sciences Group since the end of July when I first introduced the company. Sales of the best sugar substitute in the world are starting to take off, and the stock, like so many of it's non energy brethren, is cheap and poised to rebound. 

As a refresher course, HESG is just getting started marketing the world's best sugar substitute, Shugr™. Zero calories, zero carbs, tastes exactly like sugar, bakes and mixes exactly like sugar, and is made from 99.5% natural ingredients.

Shugr™ is derived from a blend of erythritol and tagatose which occurs naturally in many fruits and vegetables. Shugr™ has a patent pending and its ingredients have a GRAS (Generally Recognized as Safe) designation for food safety as determined by the FDA.

The product is currently being sold through several national chains including the Vitamin Shoppe and GNC. At present, it is only available in 1.3 lb jars, but packaging is expanding. The larger quantities will come in bags for baking just like regular sugar, and packets will be offered as well for individual servings. 

If you participated in the free sample program, you can expect your free sample in the mail either late this week or sometime next week. The company had a temporary delay from the fulfillment house, but the samples are on their wait out now. Please try the product and decide for yourself.

Recent press releases provide evidence that Shugr™ is starting to get traction in the market. In a September 7th press release, HESG disclosed it was beginning to get solid order flow from mega food ingredient distributor DNP International.

In today's press release, HESG disclosed order flow from GNC was accelerating. The first reorders of the product are now coming in, and GNC is expanding the number of stores within its 5700 store international network. GNC's VP of sales believes orders will continue to accelerate for the product.

One of the things I like about this company is their willingness to listen to both the public and shareholders. Recently, I participated in a survey concerning packaging, and many of you who requested the free sample might have done so as well. In case you are interested, the coffee cup packaging won hands down vs the packaging you see above. Many simply disliked the "sugar lips" image. Packaging will be coming with a coffee cup. I'll have the image for the next edition.

After first introducing HESG in the $.92 range, the stock spiked to $1.25 with 2 trading days. Since then it's been all downhill. The market's obsession with rising energy costs have taken the luster out of nearly every other group.

However, once we get past hurricane season, the market will turn its attention back to other growth arenas. The raging diabetes epidemic in the United States will once again come back to the forefront.

HESG is close to a 52 week low, and history tells us the stock has always rebounded from these oversold levels. I believe this stock is poised for a rebound just like the 33% rebound we enjoyed in DSEN

The recent sell off has been on very low volume, and I am concerned the stock will move up too quickly off current levels. As of market close today, there were only a couple of offers in between $.70 and $.75, and then nearly none for sale to about $.90.

Look for HESG to begin it's rebound phase right now as sales of Shugr™ gain traction. A high profile customer looking to include Shugr™ in a well known food or beverage product would be heaven sent for shareholders.

Bottom line: Place a limit order for HESG up to $.75 first thing tomorrow as the stock should trade up quite easily. When you get your sample, try it yourself. I have, and I love this product. It has enormous upside.

If you want to order a free sample, simply click here and fill out the form.

Here is the complete text of today's press release for your review:
 

Brisk Shugr Sales at GNC -- Places New Order

Business Wire via COMTEX

Sep 20, 2005 4:01:11 PM

LOS ANGELES, Sep 20, 2005 (BUSINESS WIRE) --

Health Sciences Group, Inc. (OTCBB: HESG), provider of innovative nutraceutical products and functional food ingredients derived from natural sources, announced today that sales of Shugr at GNC have been brisk with GNC placing new order for more stores. With more than 5,700 doors worldwide, GNC is the nation's largest specialty retailer of nutritional supplements.

"We are excited to see that sales of Shugr have exceeded our expectations at GNC," said Fred E. Tannous, co-Chairman and Chief Executive Officer of Health Sciences Group. "With this new order from GNC, we expect to see Shugr sold in more of their retail stores nationwide. We are working with GNC to develop various in-store marketing and advertising initiatives to promote Shugr, including offering coupons for discounts on purchases of Shugr. We expect these marketing programs will further increase Shugr sales at GNC."

"As a result of the increasing demand for Shugr at GNC, we have received numerous inquiries from other retailers seeking to sell Shugr in their stores," commented Loren Miles, VP Marketing. "We expect to progressively expand distribution of Shugr in the coming months."

Shugr is the first natural, zero-calorie sweetener made from sugars that occur naturally in such good-tasting, healthy foods such as fruits, vegetables, corn and dairy products. Erythritol is a naturally-occurring sugar commonly found in melon, grapes, mushrooms and soy. Tagatose comes from dairy products, but does not affect people who are lactose intolerant. Tagatose also provides an added health benefit -- prebiotic fiber that promotes intestinal health, much the way yogurt does. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free. A trace amount of sucralose is added to give Shugr its "high note." All of these ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety from the US Food & Drug Administration.

About Health Sciences Group, Inc.

Health Sciences Group identifies, develops and commercializes innovative nutritional products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically-supported, GRAS-certified ingredients under its Swiss Research(TM) and Swiss Diet(TM) brand names. For more information, visit www.HSciences.com.

About GNC Corporation

GNC, headquartered in Pittsburgh, Pennsylvania, operates 2,644 company-owned stores in the U.S. and Canada and has 1,261 domestic franchised locations, 1,043 Rite Aid "store-within-a-store" locations and 773 international franchised locations. GNC is the largest global specialty retailer of nutritional supplements, which includes vitamin, mineral and herbal supplements (VMHS), sports nutrition products, diet and energy products and specialty supplements. For more information and to order products, including Shugr(TM), visit www.GNC.com.

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.

SOURCE: Health Sciences Group, Inc.

Health Sciences Group, Inc. Bill Glaser, President, or Fred E. Tannous, CEO 310-242-6700
Copyright Business Wire 2005


Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.


Disclaimer
The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features.  Likewise, this newsletter is owned by MarketByte, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. Health Sciences Group, Inc has paid MarketByte LLC as fee of $25,000 in cash, 200,000 newly issued restricted shares, and 200,000 warrants convertible at $.88 for ongoing coverage of the company.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies. 

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services. 

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner.  No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Dutchess Limited Partnership.  The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess Advisors.  Dutchess Advisors periodically refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter.  Dutchess Advisors may or may not own shares in the companies that it so refers to MarketByte.  MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Dutchess Advisors owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.


Unsubscribe Here

You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?.

 
 
 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

FROG Poised To Bounce
January 24, 2012

Share
Market Summary
Nasdaq 2903.88 -23.35 (-0.80%)
Russell 2K 813.33 +0.00 (+0.00%)
S&P 500 1342.64 -9.31 (-0.69%)
S&P 100 607.12 -3.98 (-0.65%)
Quotes are delayed 20 minutes.

Add to Google

China Stocks and Penny Stocks - Discover Tomorrow's Winners Today

© 2012 OTC Journal